In Vitro and Intracellular Activity of Imipenem Combined With Tedizolid, Rifabutin, and Avibactam Against Mycobacterium Abscessus

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01915-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Synergism of Rifabutin With Clarithromycin, Imipenem and Tigecycline Against the Mycobacterium Abscessus Complex

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Rifabutin Is Active Against Mycobacterium Abscessus in Mice

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

In Vitro Activity of Tedizolid Against Mycobacterium Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Author Correction: Effect of Amoxicillin in Combination With Imipenem-Relebactam Against Mycobacterium Abscessus

Scientific Reports
Multidisciplinary
2020English

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium Difficile

Frontiers in Microbiology
Microbiology
2018English

In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline Against Drug-Resistant Clinical Isolates of Mycobacterium Abscessus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Bedaquiline Eliminates Bactericidal Activity of Β-Lactams Against Mycobacterium Abscessus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam Against Carbapenem-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Impact of Β-Lactamase Inhibition on the Activity of Ceftaroline Against Mycobacterium Tuberculosis and Mycobacterium Abscessus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy